Back to RPRX
THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. → RPRX
THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. RPRX Position History
Royalty Pharma plc
Quarters held
22
Latest value
$19.5M
Q3 2026
Peak value
$27.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $11.5M |
| Q4 2025 | $1.2M |
| Q4 2025 | $15.2M |
| Q4 2025 | $8.3M |
| Q4 2025 | $10M |
| Q1 2026 | $15.4M |
| Q1 2026 | $1.6M |
| Q1 2026 | $20.6M |
| Q1 2026 | $18.9M |
| Q1 2026 | $11M |
| Q1 2026 | $13.4M |
| Q2 2026 | $13.9M |
| Q2 2026 | $19.1M |
| Q2 2026 | $1.4M |
| Q2 2026 | $27.9M |
| Q2 2026 | $22M |
| Q2 2026 | $12.6M |
| Q2 2026 | $18.6M |
| Q2 2026 | $12.1M |
| Q3 2026 | $14.6M |
| Q3 2026 | $2.6M |
| Q3 2026 | $19.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $19.5M | 400 | — | — |
| Q3 2026 | $2.6M | 53 | — | — |
| Q3 2026 | $14.6M | 300 | — | — |
| Q2 2026 | $12.1M | 260 | — | — |
| Q2 2026 | $18.6M | 400 | — | — |
| Q2 2026 | $12.6M | 270 | — | — |
| Q2 2026 | $22M | 393 | — | — |
| Q2 2026 | $27.9M | 600 | — | — |
| Q2 2026 | $1.4M | 31 | — | — |
| Q2 2026 | $19.1M | 410 | — | — |
| Q2 2026 | $13.9M | 300 | — | — |
| Q1 2026 | $13.4M | 260 | — | — |
| Q1 2026 | $11M | 215 | — | — |
| Q1 2026 | $18.9M | 393 | — | — |
| Q1 2026 | $20.6M | 400 | — | — |
| Q1 2026 | $1.6M | 31 | — | — |
| Q1 2026 | $15.4M | 300 | — | — |
| Q4 2025 | $10M | 260 | — | — |
| Q4 2025 | $8.3M | 215 | — | — |
| Q4 2025 | $15.2M | 393 | — | — |
| Q4 2025 | $1.2M | 31 | — | — |
| Q4 2025 | $11.5M | 300 | — | — |